Literature DB >> 2292229

The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury.

J L Mehta1, W W Nichols.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292229     DOI: 10.2165/00003495-199040050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  62 in total

1.  Reduction of the vein graft occlusion rate after coronary artery bypass surgery by treatment with a thromboxane receptor antagonist.

Authors:  R W Hacker; M Torka; I Yükseltan; V Pohlmann; P Meier; T Zimmermann; H Etti
Journal:  Z Kardiol       Date:  1989

2.  Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis.

Authors:  K Kondo; R Seo; M Naka; T Kitagawa; K Wakitani; M Sakata; H Kira; T Okegawa; A Kawasaki
Journal:  Eur J Pharmacol       Date:  1989-04-25       Impact factor: 4.432

3.  Elevation of cytoplasmic free calcium concentration by stable thromboxane A2 analogue in human platelets.

Authors:  Y Kawahara; J Yamanishi; Y Furuta; K Kaibuchi; Y Takai; H Fukuzaki
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

4.  Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.

Authors:  D J Fitzgerald; F Wright; G A FitzGerald
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

5.  Antiarrhythmic effects of the thromboxane antagonist BM 13.177.

Authors:  C L Wainwright; J R Parratt
Journal:  Eur J Pharmacol       Date:  1987-01-20       Impact factor: 4.432

6.  Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction.

Authors:  M Tada; S Hoshida; T Kuzuya; M Inoue; T Minamino; H Abe
Journal:  Int J Cardiol       Date:  1985-07       Impact factor: 4.164

7.  Thromboxane A2 in acute myocardial infarction.

Authors:  P Walinsky; J B Smith; A M Lefer; M Lebenthal; P Urban; A Greenspon; S Goldberg
Journal:  Am Heart J       Date:  1984-10       Impact factor: 4.749

8.  The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.

Authors:  J Mehta; P Mehta; C Horalek
Journal:  Am Heart J       Date:  1983-06       Impact factor: 4.749

9.  Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.

Authors:  G J Grover; W A Schumacher
Journal:  J Pharmacol Exp Ther       Date:  1989-02       Impact factor: 4.030

10.  Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

Authors:  A J Marcus; B B Weksler; E A Jaffe; M J Broekman
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more
  1 in total

1.  Aspirin resistance: Fact or fiction? A point of view.

Authors:  Jawahar L Mehta; Bhavna Mohandas
Journal:  World J Cardiol       Date:  2010-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.